Patients with Parkinson disease (PD) who use inappropriate antipsychotics may be at an increased risk for pneumonia compared with patients with PD who use more appropriate atypical antipsychotics.
Compared with the general population, patients with bipolar disorder (BD) have an increased risk of developing idiopathic Parkinson disease (PD), study results published in JAMA Neurology suggest. Published studies that included data on the risk for PD in patients with BD vs the general population without BD were included in a systematic review. A total…
Nourianz is now available as an adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson disease (PD) experiencing “off” episodes.
Elevated plasma neurofilament light chain (NfL) levels are associated with higher disease severity and dementia in patients with Parkinson disease.
The perception of motor and non-motor function of patients with Parkinson disease (PD) is associated with objective PD motor severity.
A global collaboration aimed to identify patients and families with genetic Parkinson disease (PD) has led to a 3-fold higher detection rate of genetic PD, compared to the number of cases reported in the literature.
High intensity interval training may increase serum brain-derived neurotrophic factor levels in patients with idiopathic Parkinson disease, along with improvement of neuroplasticity and quality of life.
Pathological gambling was recently identified as a complication of Parkinson disease and its pharmacological treatment, especially high-dose dopaminergic agonists.
The Food and Drug Administration has expanded the indication of abobotulinumtoxinA to include the treatment of upper limb spasticity in patients aged 2 years and older.
Compared with adults without cerebral palsy, adults with cerebral palsy had higher age-standardized prevalence of mental health disorders, including anxiety and mood affective disorders.
